Homocysteine

Homocysteine is a sulfur-containing amino acid your body produces naturally when it breaks down methionine, an essential amino acid found in protein-rich foods such as meat, eggs, dairy, and fish. In functional and integrative medicine, homocysteine is often described as a metabolic “crossroads” because your body must process it efficiently through two main pathways to keep levels in a healthy range.

The first pathway is remethylation, where homocysteine is converted back into methionine. This pathway relies on vitamin B12 and folate (vitamin B9). Remethylation supports methylation, a foundational cellular process that influences gene expression, neurotransmitter production, detoxification processes, and DNA repair. The second pathway is transsulfuration, where homocysteine is converted into cysteine, which is used to produce glutathione—a major antioxidant that helps protect cells from oxidative stress. This pathway depends on vitamin B6.

When these pathways are supported—through adequate folate, B12, and B6 intake and healthy enzyme function—homocysteine stays balanced. When the body lacks these nutrients, has difficulty absorbing or using them, or has genetic variants that reduce enzyme efficiency (such as the MTHFR variant), homocysteine can build up in the blood. Elevated homocysteine (hyperhomocysteinemia) therefore often signals that methylation and related detoxification/antioxidant pathways are under strain.

Homocysteine is clinically important because elevated levels are linked to increased risk across several major body systems—particularly the cardiovascular and nervous systems—and because it is often modifiable through targeted nutrition and lifestyle strategies. When homocysteine accumulates, it can damage the endothelium (the inner lining of blood vessels) through multiple mechanisms: it increases oxidative stress (free-radical burden), reduces nitric oxide availability (nitric oxide helps blood vessels relax and maintain healthy flow), promotes inflammation, and encourages clot formation. Over time, these changes can contribute to atherosclerosis (hardening and narrowing of arteries), increasing the likelihood of heart attack, stroke, and peripheral vascular disease.

Large population research, including findings from the Framingham cohorts, has repeatedly shown that higher homocysteine levels—particularly above 15 μmol/L—are associated with higher rates of cardiovascular events and stroke. Elevated homocysteine can also amplify risk even when traditional markers such as LDL-cholesterol appear normal, making it useful for identifying “hidden” vascular vulnerability.

Homocysteine is also strongly associated with brain health outcomes. Higher levels are linked with cognitive decline, dementia, and Alzheimer’s disease, likely due to oxidative stress in neurons and impaired methylation processes that support neurotransmitter production and neural repair. Because methylation is necessary for producing mood-related neurotransmitters such as serotonin and dopamine, elevated homocysteine has also been associated with increased risk of depression in observational studies.

Beyond heart and brain health, high homocysteine is linked to reduced bone integrity. It may interfere with collagen cross-linking (a structural process important for bone strength), increasing risk of osteoporosis and fractures, especially in older adults and postmenopausal women. During pregnancy, elevated homocysteine is associated with adverse pregnancy outcomes, including increased risk of neural tube defects and complications.

From a functional medicine lens, homocysteine is valuable because it sits at the intersection of methylation, detoxification, antioxidant production, and vascular function. When elevated, it is often a sign that foundational nutrient pathways need support—and the encouraging point is that this biomarker commonly improves with targeted, evidence-based interventions.

Reference ranges

• Optimal: <10 nanomol/L

• Mildly elevated: 10-30 nanomol/L

• Moderately elevated; 30-100 nanomol/L

• Very elevated: >100 nanomol/L

Dietary factors

Homocysteine is highly sensitive to dietary intake of folate, vitamin B12, and vitamin B6, which are required to process it through remethylation and transsulfuration. Folate-rich foods include dark leafy greens (spinach, kale, Swiss chard), legumes (lentils, chickpeas, beans), asparagus, Brussels sprouts, broccoli, and avocado. Vitamin B12 is found mainly in animal foods such as eggs, dairy, fish (salmon, sardines, mackerel), shellfish, poultry, and meats. Vitamin B6 sources include chickpeas, salmon, poultry, potatoes (especially with skin), bananas, and pistachios. Research suggests a large proportion of elevated homocysteine in the general population is linked to low intake or low blood levels of these nutrients. Dietary fibre—especially from vegetables, fruits (berries and citrus), and mushrooms—has also been associated with lower homocysteine, possibly through broader metabolic support. Betaine (trimethylglycine/TMG), found in beets, spinach, quinoa, and wheat bran, can directly support homocysteine lowering by donating methyl groups for remethylation.
[3][8][9][10][11]

Lifestyle factors

Smoking is consistently linked to higher homocysteine, and quitting can help normalise levels over time. High coffee intake (more than 4–5 cups/day) has been associated with higher homocysteine, while moderate intake appears less problematic. Alcohol has a dose-related effect: excessive intake tends to raise homocysteine by depleting and impairing B-vitamin metabolism, whereas very moderate intake may not have the same effect. Regular physical activity is protective, with active individuals showing lower homocysteine on average—likely due to improved metabolic efficiency. Chronic stress may raise homocysteine by increasing metabolic demand on methylation pathways and nutrient reserves.
[12][13][14][15][16]

Related biomarkers and micronutrients

Kidney function is a major regulator because kidneys help clear homocysteine; reduced kidney function (e.g., higher creatinine or lower eGFR) is commonly associated with higher homocysteine. Elevated homocysteine often clusters with cardiometabolic risk patterns such as higher BMI, higher blood pressure, and less favourable lipid profiles (higher triglycerides and LDL, lower HDL), compounding vascular risk. Genetic variants also influence levels—most commonly MTHFR C677T, which reduces folate-processing efficiency and tends to raise homocysteine when folate intake is insufficient. When homocysteine rises, its precursor S-adenosylhomocysteine (SAH) also accumulates and can inhibit methylation reactions, potentially worsening downstream cellular functions such as detoxification capacity and neurotransmitter synthesis.
[3][4][14][16][20]

Environmental influences

Homocysteine is primarily influenced by nutrition, lifestyle exposures (especially smoking), and underlying metabolic and kidney health rather than a single environmental toxin.

Actionable recommendations

If your results are high

Your results are high, meaning homocysteine is elevated and may signal reduced methylation efficiency and increased vascular and neurological risk.

Diet:

• Increase folate intake by eating 2–3 cups of dark leafy greens daily (spinach, kale, Swiss chard) and include 1–2 servings of legumes daily (½–1 cup cooked lentils, chickpeas, or beans).

• Add cruciferous vegetables such as broccoli, Brussels sprouts, and asparagus 4–5 times weekly.

• Ensure adequate B12 by eating 3–4 oz of fatty fish 2–3 times weekly (salmon, sardines, mackerel), plus 1–2 eggs daily (preferably pasture-raised), and consider fermented dairy like yogurt or kefir (1 cup daily) if tolerated.

• For B6 support, include chickpeas/legumes regularly, bananas (1 daily), organic poultry (4–6 oz, 2–3 times weekly), and nuts such as pistachios (¼ cup daily).

• Add betaine-rich foods like beets (1–2 medium beets or 1 cup beet juice, 3–4 times weekly), spinach, and quinoa (½–1 cup cooked, 3–4 times weekly).

• Reduce processed foods and refined sugars.
  [3][9][10][11].

Lifestyle:

• Prioritise smoking cessation if applicable.

• Keep coffee to no more than 2–3 cups/day and limit alcohol to ≤1 drink/day for women or ≤2 for men, or consider avoiding alcohol if levels are significantly elevated.

• Aim for at least 150 minutes/week of moderate-intensity exercise (brisk walking, cycling, swimming) plus 2 resistance sessions weekly.

• Support stress regulation with practices like meditation (10–20 minutes daily) or yoga (2–3 times weekly) and aim for 7–9 hours sleep nightly.
  [12][13][14][15][16].

Supplements:

• Under healthcare guidance, consider targeted B-vitamin supplementation using activated forms: methylfolate (5-MTHF) 800 mcg–1 mg daily, methylcobalamin (B12) 400–1000 mcg daily, and pyridoxal-5-phosphate (P5P, B6) 25–50 mg daily.

• Evidence from network meta-analysis supports strong homocysteine reductions with combinations such as 1 mg methylfolate + B6 + B12, and folate alone or folate + B12 can also be effective.

• Betaine (TMG) 3–6 g/day may reduce homocysteine but should be used with professional oversight as it may affect lipid levels.

• NAC (600–1200 mg/day) may support glutathione production.
  [9][22][23].

Additional tests:

• Check serum B12 and methylmalonic acid (MMA) for true B12 status

• serum or RBC folate

• B6 (P5P)

• kidney function (creatinine

• eGFR). If levels remain elevated despite adequate intake

• consider MTHFR testing (C677T/A1298C) and

• where appropriate

• other variants (MTR

• MTRR

• CBS). Very high levels (e.g.

• >30–50 μmol/L) warrant specialist review to exclude rare inherited metabolic disorders. Medical supervision is recommended when elevations are significant or persistent.
  [14][16][20][21][22]

If your results are low

Your results are low (often <5–6 μmol/L), which is uncommon. The clinical significance of low homocysteine is not clearly established and is generally not considered a concern in the way elevated levels are.

Diet:

• Continue a balanced whole-food diet with a wide variety of vegetables, fruits, whole grains, legumes, healthy fats, and high-quality proteins.

• Aim for adequate (but not excessive) protein intake, typically 0.8–1.2 g/kg/day depending on activity level.
  [10][11].

Lifestyle:
Maintain regular exercise and overall healthy habits.

Supplements:
No extra supplementation is generally required unless advised by your clinician.

Additional tests to consider:
Typically not required unless there are symptoms or broader clinical concerns.

1. Moretti R, Caruso P. The controversial role of homocysteine in neurology: From labs to clinical practice. International Journal of Molecular Sciences. 2019;20(1):E231. doi:10.3390/ijms20010231.

2. Esse R, Barroso M, Tavares de Almeida I, Castro R. The contribution of homocysteine metabolism disruption to endothelial dysfunction: State-of-the-art. International Journal of Molecular Sciences. 2019;20(4):E867. doi:10.3390/ijms20040867.

3. Zaric BL, Obradovic M, Bajic V, et al. Homocysteine and hyperhomocysteinaemia. Current Medicinal Chemistry. 2019;26(16):2948-2961. doi:10.2174/0929867325666180313105949.

4. Škovierová H, Vidomanová E, Mahmood S, et al. The molecular and cellular effect of homocysteine metabolism imbalance on human health. International Journal of Molecular Sciences. 2016;17(10):E1733. doi:10.3390/ijms17101733.

5. Djuric D, Jakovljevic V, Zivkovic V, Srejovic I. Homocysteine and homocysteine-related compounds: An overview of the roles in the pathology of the cardiovascular and nervous systems. Canadian Journal of Physiology and Pharmacology. 2018;96(10):991-1003. doi:10.1139/cjpp-2018-0112.

6. Goldstein LB, Adams R, Alberts MJ, et al. Primary prevention of ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council (and affiliated councils); the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37(6):1583-1633. doi:10.1161/01.STR.0000223048.70103.F1.

7. Zhou F, He Y, Xie X, et al. Homocysteine and multiple health outcomes: An outcome-wide umbrella review of meta-analyses and Mendelian randomization studies. Advances in Nutrition. 2025;16(6):100434. doi:10.1016/j.advnut.2025.100434.

8. Selhub J. The many facets of hyperhomocysteinemia: Studies from the Framingham cohorts. The Journal of Nutrition. 2006;136(6 Suppl):1726S-1730S. doi:10.1093/jn/136.6.1726S.

9. Liu C, Yao H, Wang F. Effect of nutritional supplements for reducing homocysteine levels in healthy adults: A systematic review and network meta-analysis of randomized trials. Nutrition Reviews. 2025;83(7):e1533-e1543. doi:10.1093/nutrit/nuae191.

10. Tajima A, Kubo Y, Horiguchi S, Shoji K, Kawabata T. Relationship between serum homocysteine concentration and dietary factors in young Japanese women. Nutrients. 2023;15(22):4740. doi:10.3390/nu15224740.

11. Konstantinova SV, Vollset SE, Berstad P, et al. Dietary predictors of plasma total homocysteine in the Hordaland Homocysteine Study. British Journal of Nutrition. 2007;98(1):201-210. doi:10.1017/S0007114507691788.

12. Yang Y, Zeng Y, Yuan S, et al. Prevalence and risk factors for hyperhomocysteinemia: A population-based cross-sectional study from Hunan, China. BMJ Open. 2021;11(12):e048575. doi:10.1136/bmjopen-2020-048575.

13. Nygård O, Refsum H, Ueland PM, Vollset SE. Major lifestyle determinants of plasma total homocysteine distribution: The Hordaland Homocysteine Study. The American Journal of Clinical Nutrition. 1998;67(2):263-270. doi:10.1093/ajcn/67.2.263.

14. Han L, Liu Y, Wang C, et al. Determinants of hyperhomocysteinemia in healthy and hypertensive subjects: A population-based study and systematic review. Clinical Nutrition. 2017;36(5):1215-1230. doi:10.1016/j.clnu.2016.11.011.

15. Ganji V, Kafai MR. Demographic, health, lifestyle, and blood vitamin determinants of serum total homocysteine concentrations in the Third National Health and Nutrition Examination Survey, 1988-1994. The American Journal of Clinical Nutrition. 2003;77(4):826-833. doi:10.1093/ajcn/77.4.826.

16. Refsum H, Nurk E, Smith AD, et al. The Hordaland Homocysteine Study: A community-based study of homocysteine, its determinants, and associations with disease. The Journal of Nutrition. 2006;136(6 Suppl):1731S-1740S. doi:10.1093/jn/136.6.1731S.

17. Stabler SP. Alterations in sulfur amino acids as biomarkers of disease. The Journal of Nutrition. 2020;150(Suppl 1):2532S-2537S. doi:10.1093/jn/nxaa118.

18. Perła-Kaján J, Jakubowski H. Dysregulation of epigenetic mechanisms of gene expression in the pathologies of hyperhomocysteinemia. International Journal of Molecular Sciences. 2019;20(13):E3140. doi:10.3390/ijms20133140.

19. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. The New England Journal of Medicine. 1998;338(15):1042-1050. doi:10.1056/NEJM199804093381507.

20. Yi P, Melnyk S, Pogribna M, et al. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. The Journal of Biological Chemistry. 2000;275(38):29318-29323. doi:10.1074/jbc.M002725200.

21. González-Lamuño D, Arrieta-Blanco FJ, Fuentes ED, et al. Hyperhomocysteinemia in adult patients: A treatable metabolic condition. Nutrients. 2023;16(1):135. doi:10.3390/nu16010135.

22. Pokushalov E, Ponomarenko A, Bayramova S, et al. Effect of methylfolate, pyridoxal-5′-phosphate, and methylcobalamin (Soloways™) supplementation on homocysteine and low-density lipoprotein cholesterol levels in patients with methylenetetrahydrofolate reductase, methionine synthase, and methionine synthase reductase polymorphisms: A randomized controlled trial. Nutrients. 2024;16(11):1550. doi:10.3390/nu16111550.

23. Vezzoli A, Dellanoce C, Caimi TM, et al. Influence of dietary supplementation for hyperhomocysteinemia treatments. Nutrients. 2020;12(7):E1957. doi:10.3390/nu12071957.